Fate Therapeutics, Inc.FATENASDAQ
LOADING
|||
Operating Income Contraction
Trending lower, below historical average, strong compound growth.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$-210.28M
↓ 59% below average
Average (9y)
$-132.39M
Historical baseline
Range
High:$-27.78M
Low:$-308.39M
CAGR
+25.2%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-210.28M | -10.4% |
| 2023 | $-190.51M | +38.2% |
| 2022 | $-308.39M | -42.1% |
| 2021 | $-216.99M | -69.4% |
| 2020 | $-128.09M | -27.2% |
| 2019 | $-100.73M | -50.1% |
| 2018 | $-67.09M | -59.3% |
| 2017 | $-42.13M | -31.8% |
| 2016 | $-31.96M | -15.0% |
| 2015 | $-27.78M | - |